NIBEC (the Nano Intelligent Biomedical Engineering Corporation)’s transformative carrier platform is delivering macromolecular drugs to cell and tissue targets throughout the body with improved ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Caitlyn Miller’s interest in cancer started when her stepfather was diagnosed with oral cancer when she was 10 years old. His diagnosis kicked off a 14-year battle that included different treatments ...

For chronic conditions such as rheumatoid arthritis, treatment often involves lifelong injections. Fear of needles, injection-associated infection and pain are responsible for patients skipping doses, ...

Researchers have discovered an enzyme, PapB, that can ‘tie off’ therapeutic peptides into stable rings, which could help ...

A new study describes one of the first entirely new drug delivery microencapsulation approaches in decades. A new study from the University of Michigan describes one of the first entirely new drug ...

For all of the benefit that biologic drugs provide as treatments for chronic conditions, these medications also require chronic dosing by injection or infusion. Biotech companies have been pursuing ...

Fail fast and fail cheap is the current mantra in drug discovery. This approach is based on the premise that elimination of high-risk compounds early in the discovery process increases the success ...

Taking medications on time, in the right dose and for the prescribed duration can be challenging for patients, and failure to do so comes with steep costs, causing 10% of hospitalizations and billions ...